Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) γ2 gene in healthy individuals

Clinical Endocrinology

Volumn 57, Issue 4, 2002, Pages 481-486

  Vaccaro, O ^a,c   Mancini, F P ^a,b   Ruffa, G ^a   Sabatino, L ^a   Iovine, C ^a   Masulli, M ^a   Colantuoni, V ^a,b   Riccardi, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SANNIO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CAUCASIAN; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GENETIC POLYMORPHISM; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MEASUREMENT; NORMAL HUMAN; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; DNA-BINDING PROTEINS; FASTING; FATTY ACIDS, NONESTERIFIED; FEMALE; HETEROZYGOTE; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0036399092     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01618.x     Document Type: Article

References (36)

1. Altshuler, D., Hirschhorn, J.N., Klannemark, M., Lindgrem, C.M., Gaudet, D., Hudson, T.J., Daly, M., Groop, L. & Lasnder, E.S. (2000) The common PPAR-γ2 Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genetics, 26, 76-80.
2. Barroso, I., Gurnell, M., Crowley, V.E.F., Agostini, M., Schwabe, J.W., Soos, M.A., Li Maslen, G., Williams, T.D.M., Lewis, H., Schafer, A.J., Chatterjee, W.K.K. & O'Rahilly, S. (1999) Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature, 402, 880-883.
3. Beamer, B.A., Yen, C.-J., Andersen, R.E., Muller, D., Elahi, D., Cheskin, L.J., Andres, R., Roth, J. & Shuldiner, A.R. (1998) Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor γ2 gene with obesity in two Caucasian populations. Diabetes, 47, 1806-1808.
4. Boden, G. (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes, 46, 3-10.
5. Bonadonna, R. & Bonora, E. (1997) Glucose and free fatty acid metabolism in human obesity: relationship to insulin resistance. Diabetes Reviews, 1 (5), 21-51.
6. Bonora, E., Targher, G., Alberiche, M., Bonadonna, R., Saggiani, F., Zenere, M., Monauni, T. & Muggeo, M. (2000) Homeostasis Model Assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care, 23, 57-63.
7. Deeb, S.S., Fajas, L., Nemoto, M., Pihlajamaki, J., Mykkanen, L., Kuusisto, J., Laakso, M., Fujimoto, W. & Auwerx, J. (1998) A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nature Genetics, 20, 284-287.
8. Ek, J., Urhammer, S.A., Sorensen, T.I.A., Andersen, T., Auwerx, J. & Pedersen, O. (1999) Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-γ2 (PPAR-γ2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia, 42, 892-895.
9. El-Deriny, S., Ng, R.H. & Statland, B.E. (1986) Evaluation of the Kodak Ektakem DT-60 analyzer. Clinical Chemistry, 32, 415-419.
10. Fajas, L., Debril, M.B. & Auwerx, J. (2001) PPARγ: an essential role in metabolic control. Nutrition, Metabolism, and Cardiovascular Diseases, 11, 64-69.
11. Gervois, P., Pinede Torra, I., Fruchart, J.C. & Staels, B. (2000) Regulation of lipid and lipoprotein metabolism by PPAR activators. Clinical Chemistry and Laboratory Medicine, 38, 3-11.
12. Hu, E., Kim, J.K., Sarraf, P. & Spiegelman, B.M. (1996) Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science, 247, 2100-2103.
13. Jacob, S., Stumvoll, M., Becker, R., Koch, M., Nielsen, M., Loblein, K., Maerker, E., Volk, A., Renn, W., Balletshofer, B., Machicao, F., Rett, K. & Haring, H.U. (2000) The PPARgamma2 polymorphism Pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients. Hormone and Metabolism Research, 32, 413-416.
14. Kadowaki, T. (2000) Insights into insulin resistance and type 2 diabetes from knockout mouse models. Journal of Clinical Investigation, 106, 459-465.
15. Koch, M., Rett, K., Maeker, E., Volk, A., Haist, K., Deninger, M., Renn, W. & Haring, H.U. (1999) The PPAR-γ2 aminoacid polymorphism Pro12Ala is prevalent in offspring of type 2 diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects. Diabetologia, 42, 758-762.
16. Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H., Yamauchi, T., Komeda, K., Satoh, S., Nakano, R., Sugiyama, T., Eto, K., Tsubamoto, Y., Okuno, A., Murakami, K., Sekihara, H., Hasegawa, G., Naito, M., Toyoshima, Y., Tanaka, T., Shiota, K., Kitamura, T., Fujita, T., Ezaki, O., Aizawa, S., Nagai, R., Tobe, K., Kimura, S. & Kadowaki, T. (1999) PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Molecular Cell, 4, 597-609.
17. Mancini, F.P., Vaccaro, O., Sabatino, L., Tufano, A., Rivellese, A.A., Riccardi, G. & Colantuoni, V. (1999) The Pro12Ala substitution in the peroxisome proliferator-activated receptor γ2 is not associated with type 2 diabetes. Diabetes, 48, 1466-1468.
18. Marotta, G., Auletta, P., Liguori, M., Turbati, M., Riccardi, G. & Vaccaro, O. (1994) Uso della chimica a secco in una campagna per l'identificazione dei fattori di rischio per le malattie cardiovascolari. Epidemiologia e Prevenzione, 18, 224-229.
19. Martin, G., Schoonjans, K., Steals, B. & Auwerx, J. (1988) PPARγ activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes. Atherosclerosis, 137, 575-580.
20. Miles, P.D.G., Barak, Y., Evans, R.M. & Olefsky, J.M. (2000) Improved insulin-sensitivity in mice heterozygous for PPARγ deficiency. Journal of Clinical Investigation, 105, 287-292.
21. Miller, S.A., Dykes, D.D. & Polesky, U.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215-1218.
22. Mori, Y., Kim-Motoyama, H., Katakura, T., Yasuda, K., Kadowaki, H., Beamer, B.A., Shuldino, A.R., Akanum, Y. & Kadowaki, T. (1999) Effect of the human peroxisome proliferator-activated receptor γ2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men. Biochemical and Biophysical Research Communications, 251, 195-198.
23. Nisoli, E., Carruba, M.O., Tonello, M.C., Macor, C., Federspil, G. & Vettor, R. (2000) Induction of fatty acid translocase/CD36, peroxi-some proliferator-activated receptor-γ2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-α gene expression in human subcutaneous fat by lipid infusion. Diabetes, 49, 319-324.
24. Olefsky, J.M. (2000) Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists. Journal of Clinical Investigation, 106 (4), 467-472.
25. Ringel, J., Engelì, S., Distler, A. & Sharma, A. (1994) Pro12Ala missense mutation of the peroxisome proliferator-activated receptor γ and diabetes mellitus. Biochemical and Biophysical Research Communications, 254, 450-453.
26. Ristow, M., Muller-Wieland, D., Pfeiffer, A., Krone, W. & Khan, R. (1998) Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. New England Journal of Medicine, 339, 953-959.
27. Roth, J. & Gorden, P. (1973) Clinical application of the insulin assay. In Methods in Investigative and Diagnostic Endocrinology (eds S. A. Berson & R. S. Yalow), pp. 876-882. North Holland, Amsterdam.
28. Schwartz, M.W. & Kahn, S.E. (1999) Insulin resistance and obesity. Nature, 402, 860-861.
29. Spiegelman, B.M. (1998) PPARγ: adipogenic regulator and thiazolidinedione receptor. Diabetes, 47, 507-514.
30. Stefan, N., Fritsche, A., Haring, H. & Stumvoll, M. (2001) Effect of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene. Diabetes, 50, 1143-1148.
31. Stumvoll, M., Gunther Wahl, H., Loblein, K., Becker, R., Machicao, F., Jacob, S. & Haring, H. (2001) Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ2 gene is associated with increased antilipolytic insulin sensitivity. Diabetes, 50, 876-881.
32. Vaccaro, O., Mancini, F.P., Ruffa, G., Sabatino, L., Colantuoni, V. & Riccardi, R. (2000) Pro12Ala mutation in the peroxisome proliferator-activated receptor γ2 (PPARγ2) and severe obesity: a case-control study. International Journal of Obesity, 24, 1195-1199.
33. Valve, R., Sivenius, K., Miettinen, R., Pihlajamaki, J., Rissanen, A., Deeb, S.S., Auwerx, J., Uusitupa, M. & Laakso, M. (1999) Two polymorphisms in the peroxisome proliferator-activated receptor-gamma2 gene are associated with severe overweight among obese women. Journal of Clinical Endocrinology and Metabolism, 84, 3708-3712.
34. Werman, A., Hollemberg, H., Solanes, G., Bjorbaek, C., Vidal-Puig, A.J. & Flier, J.S. (1997) Ligand independent activation domain in the N terminus of peroxisome proliferator-activated receptor γ (PPARγ). Differential activity of PPARγ1 and 2 isoforms and influence of insulin. Journal of Biological Chemistry, 272, 20230-20235.
35. Yamauchi, T., Kamon, J., Waki, H., Murakami, K., Motojima, K., Komeda, K., Ide, T., Kubota, N., Terauki, Y., Tobe, K., Miki, H., Tsuckida, A., Akanuma, Y., Nagai, R., Kimura, S. & Kadowaki, T. (2001) The mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance. Journal of Biological Chemistry, 276, 41245-41254.
36. Yen, C.J., Beamer, B.A., Negri, C., Silver, K., Brown, K.A., Yamall, D.P., Bums, D.K., Roth, J. & Shudiner, A.R. (1997) Molecular scanning of the human peroxisome proliferator activated receptor γ (PPARγ) gene in diabetic Caucasians: identification of a Pro12Ala PPARγ missense mutation. Biochemical and Biophysical Research Communications, 241, 270-274.